SNOA
Sonoma Pharmaceuticals, Inc. Common Stock
stockNASDAQ
sonoma pharmaceuticals, inc., develops and produces stabilized hypochlorous acid (hocl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the united states and internationally. the company offers epicyn, an antimicrobial facial cleanser; levicyn, a hypochlorous acid (hocl) based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; celacyn gel, a product indicated to promote healing through the management of new and old scars resulting from surgical procedures and trauma wounds or burns; sebuderm, a product indicated to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis; and ceramax, a lipogrid based skin barrier cream for management of dry itchy skin, minor skin irritations, rashes, and inflammation caused by various skin conditions, as well as loyon for the management of skin scal
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.11 | 2026-11-06 | -1.80% | 2.442 |
| 1M | 1.18 | 2026-10-13 | -7.63% | 1.331 |
| 3M | 1.34 | 2026-08-13 | -18.66% | 1.234 |
| 6M | 1.15 | 2026-05-13 | -5.22% | 1.529 |
| 1Y | 3.54 | 2025-11-13 | -69.21% | 1.196 |
| 2Y | 2.61 | 2024-11-13 | -58.24% | — |
| 5Y | 115.60 | 2021-11-12 | -99.06% | 1.100 |
Sonoma Pharmaceuticals, Inc. Common Stock (NASDAQ:SNOA) stock price today is $1.09, and today's volume is 92,828. SNOA is down 6.838% today. The 30 day average volume is 54,796. SNOA market cap is $5.52M with 5.06M shares outstanding.